Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocks.
Campylobacteriosis is the most frequent food-borne human enteritis. The major source for infection with Campylobacter spp. is broiler meat. Risk assessments consider the reduction of Campylobacter in primary production to be most beneficial for human health. The aim of this study was to test the efficacy of a bacteriophage application under commercial conditions which had proved to be effective in previous noncommercial studies under controlled experimental conditions. A phage cocktail for Campylobacter reduction was tested on three commercial broiler farms each with a control and an experimental group. Colonization of Campylobacter was confirmed prior to phage application in fecal samples. Subsequently, a phage cocktail was applied via drinking water in the experimental group (log10 5.8 to 7.5 PFU/bird). One day after phage application, Campylobacter counts of one experimental group were reduced under the detection limit (<50 CFU/g, P=0.0140) in fecal samples. At slaughter, a significant reduction of >log10 3.2 CFU/g cecal content compared to the control was still detected (P=0.0011). No significant reduction was observed in the experimental groups of the other trials. However, a significant drop in cecal Campylobacter counts occurred in a phage-contaminated control. These results suggest that maximum reduction of Campylobacter at the slaughterhouse might be achieved by phage application 1 to 4 days prior to slaughter.
Institute for Food Quality and Food Safety, University of Veterinary Medicine Hannover, Hannover, Germany.
Sophie
S
Kittler
Samuel
S
Fischer
Amir
A
Abdulmawjood
Gerhard
G
Glünder
Günter
G
Klein
D058491:Bacterial Load; D001435:Bacteriophages / Q000254:growth & development*; D001691:Biological Therapy / Q000379:methods*; D002169:Campylobacter Infections / Q000382:microbiology / Q000628:therapy* / Q000662:veterinary*; D016123:Campylobacter jejuni / Q000302:isolation & purification* / Q000821:virology*; D002353:Carrier State / Q000382:microbiology / Q000628:therapy / Q000662:veterinary; D005243:Feces / Q000382:microbiology; D016896:Treatment Outcome